I think we are overlooking an immediate bump in our price soon. The China deal said they would provide many peptide configurations within a week to be tested on infected blood in a lab. Then 4 or 5 of the most robust configurations would be sent for animal safety testing. After that would be human trials because animals don’t have the same peptide reaction as humans do so only safety testing was to be done on animals.
So my point is, it is possible in 1-2 weeks we get a PR that our peptides completely erraticated Covid 19. Imagine the increase in share price if we announce we have a working vaccine that needs 30 days of animal safety testing, and then human trials in China? Yummy!
(6)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.